NasdaqGM:IRMDMedical Equipment
The Bull Case For IRADIMED (IRMD) Could Change Following Q1 Results And Reaffirmed 2026 Guidance - Learn Why
In early May 2026, IRADIMED CORPORATION reported first-quarter results showing sales of US$21.98 million and net income of US$5.82 million, alongside board approval of a regular US$0.20 per-share quarterly dividend payable on May 29, 2026 to shareholders of record on May 15, 2026.
The company also issued earnings guidance for the second quarter and reaffirmed full-year 2026 revenue and GAAP diluted EPS targets, underscoring management’s confidence in its operating outlook.
We’ll now...